nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—Anaemia—Bleomycin—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Trandolapril—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Trandolapril—Asthenia—Teniposide—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Trandolapril—Malaise—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Trandolapril—Pruritus—Teniposide—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Trandolapril—Arrhythmia—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Trandolapril—Leukopenia—Bleomycin—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Trandolapril—Cardiac disorder—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Trandolapril—Alopecia—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Trandolapril—Body temperature increased—Fludarabine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Trandolapril—Mental disorder—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Trandolapril—Malnutrition—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Trandolapril—Cough—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Trandolapril—Angiopathy—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Trandolapril—Diarrhoea—Teniposide—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Trandolapril—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Trandolapril—Chest pain—Bleomycin—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Trandolapril—Myalgia—Bleomycin—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Trandolapril—Alopecia—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Trandolapril—Back pain—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Trandolapril—Discomfort—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Trandolapril—Mental disorder—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Trandolapril—Urine output increased—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Trandolapril—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Trandolapril—Alopecia—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Trandolapril—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Trandolapril—Oedema—Bleomycin—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Trandolapril—Infection—Bleomycin—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Trandolapril—Anaemia—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Trandolapril—Back pain—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Trandolapril—Vomiting—Teniposide—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Trandolapril—Agitation—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Trandolapril—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Trandolapril—Asthenia—Fludarabine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Trandolapril—Rash—Teniposide—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Trandolapril—Dermatitis—Teniposide—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Trandolapril—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Trandolapril—Headache—Teniposide—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Trandolapril—Pruritus—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Trandolapril—Back pain—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Trandolapril—Leukopenia—Carmustine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Trandolapril—Anorexia—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Trandolapril—Anaemia—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Trandolapril—Agitation—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Trandolapril—Polyuria—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Trandolapril—Photosensitivity—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Trandolapril—Hypotension—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Trandolapril—Diarrhoea—Fludarabine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Trandolapril—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Trandolapril—Nausea—Teniposide—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Trandolapril—Anaemia—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Trandolapril—Vertigo—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Trandolapril—Leukopenia—Vincristine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Trandolapril—Chest pain—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Myalgia—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Anxiety—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Trandolapril—Paraesthesia—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Malaise—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Trandolapril—Dyspnoea—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Trandolapril—Renal failure acute—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Trandolapril—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Trandolapril—Oedema—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Decreased appetite—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Myalgia—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Visual disturbance—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Cough—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Infection—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Vomiting—Fludarabine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Trandolapril—Rash—Fludarabine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Trandolapril—Dermatitis—Fludarabine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Trandolapril—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Trandolapril—Headache—Fludarabine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Trandolapril—Tachycardia—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Trandolapril—Myalgia—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Chest pain—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Anxiety—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Trandolapril—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Trandolapril—Discomfort—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Trandolapril—Oedema—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Trandolapril—Anorexia—Carmustine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Trandolapril—Infection—Vincristine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Trandolapril—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Trandolapril—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Trandolapril—Nervous system disorder—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Trandolapril—Thrombocytopenia—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Trandolapril—Hypotension—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Trandolapril—Oedema—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Trandolapril—Nausea—Fludarabine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Trandolapril—Infection—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Trandolapril—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Trandolapril—Shock—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Urticaria—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Anorexia—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Trandolapril—Body temperature increased—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Insomnia—Carmustine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Trandolapril—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Trandolapril—Paraesthesia—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Trandolapril—Hypotension—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Dyspnoea—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Somnolence—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Anorexia—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Trandolapril—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Trandolapril—Decreased appetite—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Trandolapril—Hypotension—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Trandolapril—Insomnia—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Trandolapril—Paraesthesia—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Trandolapril—Constipation—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Trandolapril—Breast disorder—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Trandolapril—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Trandolapril—Decreased appetite—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Trandolapril—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Trandolapril—Somnolence—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Feeling abnormal—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Fatigue—Vincristine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Asthenia—Bleomycin—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Trandolapril—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Trandolapril—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Trandolapril—Constipation—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Trandolapril—Pruritus—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Trandolapril—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Trandolapril—Eosinophilia—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Trandolapril—Fatigue—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Trandolapril—Pancreatitis—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Trandolapril—Constipation—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Trandolapril—Abdominal pain—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Trandolapril—Body temperature increased—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Trandolapril—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Trandolapril—Pancytopenia—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Trandolapril—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Trandolapril—Neutropenia—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Trandolapril—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Trandolapril—Body temperature increased—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Trandolapril—Abdominal pain—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Trandolapril—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Trandolapril—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Trandolapril—Urticaria—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Hypersensitivity—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Trandolapril—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Trandolapril—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Trandolapril—Vomiting—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Trandolapril—Infestation—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Trandolapril—Drowsiness—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Trandolapril—Infestation NOS—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Trandolapril—Depression—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Trandolapril—Rash—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Trandolapril—Dermatitis—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Trandolapril—Asthenia—Carmustine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Trandolapril—Renal failure—Methotrexate—lymphatic system cancer	0.000996	0.000996	CcSEcCtD
Trandolapril—Hypersensitivity—Vincristine—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Trandolapril—Sweating—Methotrexate—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Trandolapril—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000958	0.000958	CcSEcCtD
Trandolapril—Epistaxis—Methotrexate—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Trandolapril—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Trandolapril—Asthenia—Vincristine—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Trandolapril—Diarrhoea—Carmustine—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Trandolapril—Nausea—Bleomycin—lymphatic system cancer	0.000949	0.000949	CcSEcCtD
Trandolapril—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000945	0.000945	CcSEcCtD
Trandolapril—Asthenia—Mitoxantrone—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Trandolapril—Dizziness—Carmustine—lymphatic system cancer	0.000922	0.000922	CcSEcCtD
Trandolapril—Diarrhoea—Vincristine—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Trandolapril—Hepatitis—Methotrexate—lymphatic system cancer	0.000909	0.000909	CcSEcCtD
Trandolapril—Pharyngitis—Methotrexate—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Trandolapril—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000898	0.000898	CcSEcCtD
Trandolapril—Urethral disorder—Methotrexate—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Trandolapril—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Trandolapril—Vomiting—Carmustine—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Trandolapril—Dizziness—Vincristine—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Trandolapril—Rash—Carmustine—lymphatic system cancer	0.000879	0.000879	CcSEcCtD
Trandolapril—Dermatitis—Carmustine—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Trandolapril—Visual impairment—Methotrexate—lymphatic system cancer	0.000876	0.000876	CcSEcCtD
Trandolapril—Headache—Carmustine—lymphatic system cancer	0.000874	0.000874	CcSEcCtD
Trandolapril—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Trandolapril—Eye disorder—Methotrexate—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Trandolapril—Tinnitus—Methotrexate—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Trandolapril—Vomiting—Vincristine—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Trandolapril—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000844	0.000844	CcSEcCtD
Trandolapril—Rash—Vincristine—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Trandolapril—Dermatitis—Vincristine—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Trandolapril—Headache—Vincristine—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Trandolapril—Nausea—Carmustine—lymphatic system cancer	0.000828	0.000828	CcSEcCtD
Trandolapril—Angiopathy—Methotrexate—lymphatic system cancer	0.000825	0.000825	CcSEcCtD
Trandolapril—Vomiting—Mitoxantrone—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Trandolapril—Immune system disorder—Methotrexate—lymphatic system cancer	0.000821	0.000821	CcSEcCtD
Trandolapril—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Trandolapril—Rash—Mitoxantrone—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Trandolapril—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Trandolapril—Headache—Mitoxantrone—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Trandolapril—Alopecia—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Trandolapril—Mental disorder—Methotrexate—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Trandolapril—Malnutrition—Methotrexate—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Trandolapril—Nausea—Vincristine—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Trandolapril—Dysgeusia—Methotrexate—lymphatic system cancer	0.000775	0.000775	CcSEcCtD
Trandolapril—Nausea—Mitoxantrone—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Trandolapril—Back pain—Methotrexate—lymphatic system cancer	0.000766	0.000766	CcSEcCtD
Trandolapril—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Trandolapril—Anaemia—Methotrexate—lymphatic system cancer	0.000732	0.000732	CcSEcCtD
Trandolapril—Malaise—Methotrexate—lymphatic system cancer	0.000714	0.000714	CcSEcCtD
Trandolapril—Vertigo—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Trandolapril—Leukopenia—Methotrexate—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Trandolapril—Cough—Methotrexate—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Trandolapril—Arthralgia—Methotrexate—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Trandolapril—Chest pain—Methotrexate—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Trandolapril—Myalgia—Methotrexate—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000669	0.000669	CcSEcCtD
Trandolapril—Discomfort—Methotrexate—lymphatic system cancer	0.000666	0.000666	CcSEcCtD
Trandolapril—Infection—Methotrexate—lymphatic system cancer	0.000642	0.000642	CcSEcCtD
Trandolapril—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Trandolapril—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000632	0.000632	CcSEcCtD
Trandolapril—Skin disorder—Methotrexate—lymphatic system cancer	0.000627	0.000627	CcSEcCtD
Trandolapril—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Trandolapril—Anorexia—Methotrexate—lymphatic system cancer	0.000616	0.000616	CcSEcCtD
Trandolapril—Hypotension—Methotrexate—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000589	0.000589	CcSEcCtD
Trandolapril—Insomnia—Methotrexate—lymphatic system cancer	0.000584	0.000584	CcSEcCtD
Trandolapril—Paraesthesia—Methotrexate—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Trandolapril—Dyspnoea—Methotrexate—lymphatic system cancer	0.000576	0.000576	CcSEcCtD
Trandolapril—Somnolence—Methotrexate—lymphatic system cancer	0.000574	0.000574	CcSEcCtD
Trandolapril—Dyspepsia—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Trandolapril—Decreased appetite—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000558	0.000558	CcSEcCtD
Trandolapril—Fatigue—Methotrexate—lymphatic system cancer	0.000557	0.000557	CcSEcCtD
Trandolapril—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000532	0.000532	CcSEcCtD
Trandolapril—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000528	0.000528	CcSEcCtD
Trandolapril—Urticaria—Methotrexate—lymphatic system cancer	0.000513	0.000513	CcSEcCtD
Trandolapril—Abdominal pain—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Trandolapril—Body temperature increased—Methotrexate—lymphatic system cancer	0.000511	0.000511	CcSEcCtD
Trandolapril—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000476	0.000476	CcSEcCtD
Trandolapril—Asthenia—Methotrexate—lymphatic system cancer	0.000463	0.000463	CcSEcCtD
Trandolapril—Pruritus—Methotrexate—lymphatic system cancer	0.000457	0.000457	CcSEcCtD
Trandolapril—Diarrhoea—Methotrexate—lymphatic system cancer	0.000442	0.000442	CcSEcCtD
Trandolapril—Dizziness—Methotrexate—lymphatic system cancer	0.000427	0.000427	CcSEcCtD
Trandolapril—Vomiting—Methotrexate—lymphatic system cancer	0.000411	0.000411	CcSEcCtD
Trandolapril—Rash—Methotrexate—lymphatic system cancer	0.000407	0.000407	CcSEcCtD
Trandolapril—Dermatitis—Methotrexate—lymphatic system cancer	0.000407	0.000407	CcSEcCtD
Trandolapril—Headache—Methotrexate—lymphatic system cancer	0.000405	0.000405	CcSEcCtD
Trandolapril—Nausea—Methotrexate—lymphatic system cancer	0.000384	0.000384	CcSEcCtD
